Directori de persones
Francisco Javier Gonzalez Tallada

Francisco Javier Gonzalez Tallada

Grau: Llicenciat/da


Publicacions

  • Mayo-de-las-Casas, C; Velasco, A; Sanchez, D; Martínez-Bueno A; Garzón-Ibáñez M; Gatius, S; Ruiz-Mir?, M; Gonzalez-Tallada, X; Llordella, I; Tresserra, F; Rodríguez S; Aldeguer, E; Roman-Canal, B; Bertran-Alamillo, J; García-Peláez B; Rosell, R; Molina-Vila, MA; Matias-Guiu, X

    Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: a proof-of-concept study.

    INTERNATIONAL JOURNAL OF CANCER 147 277-284. .

    [doi:10.1002/ijc.32872]

  • Roman-Canal, B; Moiola, CP; Gatius, S; Bonnin, S; Ruiz-Miro, M; Gonzalez, E; Gonzalez-Tallada, X; Llordella, I; Hernandez, I; Porcel, JM; Gil-Moreno, A; Falcon-Perez, JM; Ponomarenko, J; Matias-Guiu, X; Colas, E

    EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer

    Cancers 11 -. .

    [doi:10.3390/cancers11060839]

  • Mota, A; Colas, E; Garcia-Sanz, P; Campoy, I; Rojo-Sebastian, A; Gatius, S; Garcia, A; Chiva, L; Alonso, S; Gil-Moreno, A; Gonzalez-Tallada, X; Diaz-Feijoo, B; Vidal, A; Ziober-Malinowska, P; Bobinski, M; Lopez-Lopez, R; Abal, M; Reventos, J; Matias-Guiu, X; Moreno-Bueno, G

    Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

    Modern Pathology 30 134-145. .

    [doi:10.1038/modpathol.2016.143]

  • Guerra, E; Vidal, A; Gatius, S; Velasco, A; Piulats, JM; Ponce, J; Tallada, XG; Pardo, B; Martin, MG; Ortega, E; Guiu, XM

    Molecular classification of grade 3 endometrioid endometrial carcinomas: A retrospective study

    VIRCHOWS ARCHIV 469 20-20. .

  • Eritja N; Santacana M; Maiques O; Gonzalez-Tallada X; Dolcet X; Matias-Guiu X

    Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: Endometrial cancer as a model

    Methods 77-78 31-40. .

    [doi:10.1016/j.ymeth.2014.11.001]

  • Azueta, Ainara; Maiques, Oscar; Velasco, Ana; Santacana, Maria; Pallares, Judith; Novell, Anna; Llombart-Cussac, Antonio; Gonzalez-Tallada, Xavier; Mozos, Ana; Prat, Jaime; Pillai, Raji; Mata, Manuel; Matias-Guiu, Xavier

    Gene expression microarray-based assay to determine tumor site of origin in a series of metastatic tumors to the ovary and peritoneal carcinomatosis of suspected gynecologic origin

    HUMAN PATHOLOGY 44 20-28. .

    [doi:10.1016/j.humpath.2012.04.018]

  • Garcia, Virginia; Velasco, Ana; Gatius, Sonia; Javier Gonzalez, F.; Matias-Guiu, Xavier

    Pulmonary small cell carcinoma metastatic to the ovary: a clinicopathologic study of one case with emphasis on the importance of p53 analysis in diagnosis.

    GYNECOLOGIC AND OBSTETRIC INVESTIGATION 70 87-90. .

    [doi:10.1159/000292911]

  • Llobet, D.; Eritja, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Domingo, M.; Santacana, M.; Gonzalez-Tallada, F. J.; Matias-Guiu, X.; Dolcet, X.

    The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.

    EUROPEAN JOURNAL OF CANCER 46 836-850. .

    [doi:10.1016/j.ejca.2009.12.025]

  • Tarragona, Jordi; Llecha, Nuria; Santacana, Maria; Lopez, Susana; Gatius, Sonia; Llobet, David; Dolcet, Xavier; Palomar-Asenjo, Victor; Javier Gonzalez-Tallada, Francisco; Matias-Guiu, Xavier

    DcR1 expression in endometrial carcinomas.

    VIRCHOWS ARCHIV 456 39-44. .

    [doi:10.1007/s00428-009-0855-2]

  • Llobet, D.; Eritja, N.; Encinas, M.; Llecha, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Gonzalez-Tallada, F. J.; Matias-Guiu, X.; Dolcet, X.

    CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.

    ONCOGENE 27 2513-2524. .

    [doi:10.1038/sj.onc.1210924]

Projectes

  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
  • ALTERACIONES MOLECULARES RELACIONADOS CON LA PROGRESION TUMORAL EN EL CANCER DE ENDOMETRIO
  • Carcinoma de endometrio. Participación de las vías de señalización, implicadas en la resistencia a la terapia antineoplasica